Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
32.63
-0.27 (-0.82%)
At close: Feb 13, 2026

SHA:688139 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
2,2532,2742,2722,8552,1191,372
Other Revenue
9.859.859.248.627.3130.08
2,2632,2842,2812,8642,1261,402
Revenue Growth (YoY)
1.18%0.13%-20.36%34.72%51.63%38.47%
Cost of Revenue
1,2151,1901,1741,4901,061695.47
Gross Profit
1,0481,0941,1071,3741,065706.56
Selling, General & Admin
531.82471.73476.68513.72388.03238.76
Research & Development
325.23306.17320.64292.47236.31150.72
Other Operating Expenses
-3.48-6.48-7.252.341.6313.03
Operating Expenses
864.23787.08793.97809.08622.71403.54
Operating Income
184.05306.58312.95564.67441.98303.02
Interest Expense
-3.81-3.41-3.51-2.69-2.89-0.08
Interest & Investment Income
63.8171.46118.6495.02483.95113.2
Currency Exchange Gain (Loss)
4.464.46-7.723.584.14-8.54
Other Non Operating Income (Expenses)
0.61-1.83-1.68-1.490.56-0.61
EBT Excluding Unusual Items
249.13377.25418.67659.1927.74406.99
Gain (Loss) on Sale of Investments
7.665.472.06-7.0110.213.83
Gain (Loss) on Sale of Assets
-0.250.23-1.6-0.76-0.52-5.27
Asset Writedown
-3.86-1.86-2.36---
Other Unusual Items
17.0320.8717.722423.4418.68
Pretax Income
269.72401.96434.49675.34960.87424.24
Income Tax Expense
5.5520.9522.4363.36111.740.11
Earnings From Continuing Operations
264.17381.01412.06611.97849.17384.12
Minority Interest in Earnings
-8.29-14.38-5.99-11.18-4.14-3.17
Net Income
255.88366.63406.07600.79845.04380.95
Net Income to Common
255.88366.63406.07600.79845.04380.95
Net Income Growth
-28.53%-9.71%-32.41%-28.90%121.82%109.24%
Shares Outstanding (Basic)
316316317318316317
Shares Outstanding (Diluted)
316316317318318326
Shares Change (YoY)
-0.35%-0.37%-0.20%0.06%-2.43%30.55%
EPS (Basic)
0.811.161.281.892.671.20
EPS (Diluted)
0.811.161.281.892.661.17
EPS Growth
-28.28%-9.38%-32.27%-28.95%127.35%60.27%
Free Cash Flow
140.26164.9672.08338.18387.11607.63
Free Cash Flow Per Share
0.440.520.231.061.221.87
Dividend Per Share
0.4700.4700.5150.4500.5000.380
Dividend Growth
-8.74%-8.74%14.44%-10.02%31.61%111.11%
Gross Margin
46.32%47.89%48.53%47.97%50.08%50.40%
Operating Margin
8.13%13.42%13.72%19.72%20.79%21.61%
Profit Margin
11.31%16.05%17.80%20.98%39.75%27.17%
Free Cash Flow Margin
6.20%7.22%3.16%11.81%18.21%43.34%
EBITDA
294.16411.38410.67626.73491.15325.87
EBITDA Margin
13.00%18.01%18.00%21.88%23.10%23.24%
D&A For EBITDA
110.11104.897.7262.0649.1722.85
EBIT
184.05306.58312.95564.67441.98303.02
EBIT Margin
8.13%13.42%13.72%19.72%20.79%21.61%
Effective Tax Rate
2.06%5.21%5.16%9.38%11.63%9.46%
Revenue as Reported
2,2632,2842,2812,8642,1261,402
Advertising Expenses
-24.8831.8225.4114.2411.5
Source: S&P Global Market Intelligence. Standard template. Financial Sources.